Expertise in
9
conditions

Gail E. Darling

200 Elizabeth St, M5G, 2C4, 
Toronto, ON, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
9
conditions
200 Elizabeth St, M5G, 2C4, 
Toronto, ON, CA 

Overview

Gail Darling practices practicing medicine in Toronto, Canada.

Darling is highly rated in 9 conditions, according to our data. Their clinical expertise encompasses Esophageal Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Lymphadenectomy.

They are actively involved in clinical research, co-authoring 215 peer reviewed articles and participating in 7 clinical trials.

Locations

200 Elizabeth St, M5G, 2C4, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Tissue Collection for Gastro-esophageal Cancer Primary Cell Line Establishment
Tissue Collection for Gastro-esophageal Cancer Primary Cell Line Establishment
Enrollment Status: Recruiting
Publish Date: May 14, 2025
Intervention Type: Other
PreOperative Treatment With chEmotheRapy or chemoRAdiatioN in esophaGeal or gastroEsophageal adenocaRcinoma
PreOperative Treatment With chEmotheRapy or chemoRAdiatioN in esophaGeal or gastroEsophageal adenocaRcinoma
Enrollment Status: Completed
Publish Date: August 28, 2024
Intervention Type: Drug, Other
Study Drug: (Epirubicin Cisplatin 5-Fluorouracil / Xeloda) OR 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel
Study Phase: Phase 2/Phase 3
Feasibility and Effectiveness of Prehabilitation in High-risk Surgical Patients
Feasibility and Effectiveness of Prehabilitation in High-risk Surgical Patients
Enrollment Status: Active_not_recruiting
Publish Date: May 08, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
The Utility of Circulating Tumour Cells and Plasma microRNA Detection to Predict the Response to Treatment in Patients With Esophageal Adenocarcinoma
The Utility of Circulating Tumour Cells and Plasma microRNA Detection to Predict the Response to Treatment in Patients With Esophageal Adenocarcinoma
Enrollment Status: Completed
Publish Date: March 08, 2024
Intervention Type: Other
The Contemporary Significance of Deep Venous Thrombosis and Pulmonary Embolus in Patients Undergoing Esophagectomy: A Pilot Study to Evaluate the Incidence of DVT and PE After Major Esophageal Resections
The Contemporary Significance of Deep Venous Thrombosis and Pulmonary Embolus in Patients Undergoing Esophagectomy: A Pilot Study to Evaluate the Incidence of DVT and PE After Major Esophageal Resections
Enrollment Status: Completed
Publish Date: February 24, 2021
A Randomized Controlled Feasibility Study Looking at Differences in Hospital Stay Variables Following Omission of Daily Routine Chest Radiographs After Pulmonary Resection.
A Randomized Controlled Feasibility Study Looking at Differences in Hospital Stay Variables Following Omission of Daily Routine Chest Radiographs After Pulmonary Resection.
Enrollment Status: Completed
Publish Date: May 01, 2020
Intervention Type: Diagnostic test
Study Phase: Phase 2
Assessment of Patient Frailty Prior to Thoracic Surgery: A Feasibility Study
Assessment of Patient Frailty Prior to Thoracic Surgery: A Feasibility Study
Enrollment Status: Completed
Publish Date: May 07, 2019
Intervention Type: Other
View 6 Less Clinical Trials

209 Total Publications

Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer.
Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 13, 2026

Frequently Asked Questions about Gail E. Darling

Is Gail E. Darling a top-rated expert for Esophageal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Gail E. Darling is classified as an Elite expert for Esophageal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gail E. Darling participate in research or clinical trials?

Yes. Gail E. Darling has published 209 articles and abstracts on conditions like Esophageal Cancer. You can view a list of Gail E. Darling's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Darling's expertise for a condition
ConditionClose
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile